enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. New Research Offers Hope in the Fight Against Alzheimer’s - AOL

    www.aol.com/lifestyle/research-offers-hope-fight...

    These proteins are beta-amyloid plaques, which accumulates around your brain’s nerve cells, or neurons, and tau proteins, which tangle inside the cells. ... Any cure would need to prevent or ...

  3. Early-stage research suggests new way to fight Alzheimer’s ...

    www.aol.com/lifestyle/early-stage-research...

    New preclinical-stage research suggests that targeting a specific protein in the brain could help clear toxic amyloid plaques typically linked to Alzheimer's disease progression.

  4. Alzheimer's drugs might get into the brain faster with new ...

    www.aol.com/news/alzheimers-drugs-might-brain...

    Right after each IV, researchers aimed the focused ultrasound on a specific amyloid-clogged part of each patient’s brain, opening the blood brain-barrier so more of that day’s dose might enter ...

  5. Amyloid plaques - Wikipedia

    en.wikipedia.org/wiki/Amyloid_plaques

    Some plaques occur in the brain as a result of aging, but large numbers of plaques and neurofibrillary tangles are characteristic features of Alzheimer's disease. [5] The plaques are highly variable in shape and size; in tissue sections immunostained for Aβ, they comprise a log-normal size distribution curve, with an average plaque area of 400 ...

  6. Dopamine treatment destroys beta-amyloid plaques in ... - AOL

    www.aol.com/dopamine-treatment-destroys-beta...

    Research published in December 2022 found injecting a form of neprilysin that can penetrate the blood-brain barrier showed the potential to reduce beta-amyloid plaques in the brain. Neprilysin ...

  7. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

  8. Donanemab – what we know about the latest Alzheimer’s drug

    www.aol.com/donanemab-know-latest-alzheimer-drug...

    Both drugs bind to amyloid, a protein which builds up in the brains of people living with Alzheimer’s disease. By binding to amyloid, the drugs are designed to help clear the build-up and slow ...

  9. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.